![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Neuroscience Section, National Institute on Drug Abuse Intramural Research Program/National Institutes of Health/Department of Health and Human Services, Baltimore, Maryland. (E.A.B., B.K., V.J., M.O., A.Z., T.S.S.); Department of Neurosciences, Division of Neuroscience Research, Medical University of South Carolina, Charleston, South Carolina (L.D.J., S.R.); Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, College of Physicians and Surgeons, Columbia University, New York, New York (Y.H., N.S., E.U., J.A.J.); and Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York (I.G., L.A.D.)
The dopamine transporter (DAT) terminates dopamine (DA) neurotransmission by reuptake of DA into presynaptic neurons. Regulation of DA uptake by D2 dopamine receptors (D2R) has been reported. The high affinity of DA and other DAT substrates for the D2R, however, has complicated investigation of the intracellular mechanisms mediating this effect. The present studies used the fluorescent DAT substrate, 4-[4-(diethylamino)-styryl]-N-methylpyridinium iodide (ASP+) with live cell imaging techniques to identify the role of two D2R-linked signaling pathways, extracellular signal-regulated kinases 1 and 2 (ERK1/2), and phosphoinositide 3 kinase (PI3K) in mediating D2R regulation of DAT. Addition of the D2/D3 receptor agonist quinpirole (0.1–10 µM) to human embryonic kidney cells coexpressing human DAT and D2 receptor (short splice variant, D2SR) induced a rapid, concentration-dependent and pertussis toxin-sensitive increase in ASP+ accumulation. The D2/D3 agonist (S)-(+)-(4aR, 10bR)-3,4,4a, 10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano-[4,3-b]-1,4-oxazin-9-ol hydrochloride (PD128907) also increased ASP+ accumulation. D2SR activation increased phosphorylation of ERK1/2 and Akt, a major target of PI3K. The mitogen-activated protein kinase kinase inhibitor 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one (PD98059) prevented the quinpirole-evoked increase in ASP+ accumulation, whereas inhibition of PI3K was without effect. Fluorescence flow cytometry and biotinylation studies revealed a rapid increase in DAT cell-surface expression in response to D2R stimulation. These experiments demonstrate that D2SR stimulation increases DAT cell surface expression and therefore enhances substrate clearance. Furthermore, they show that the increase in DAT function is ERK1/2-dependent but PI3K-independent. Our data also suggest the possibility of a direct physical interaction between DAT and D2R. Together, these results suggest a novel mechanism by which D2SRautoreceptors may regulate DAT in the central nervous system.
Address correspondence to: Dr. Toni S. Shippenberg, Integrative Neuroscience Section, NIDA IRP/NIH/DHHS, 333 Cassell Dr., Baltimore, MD 21224. E-mail: tshippen{at}intra.nida.nih.gov
Related articles in MolPharm:
This article has been cited by other articles:
|
|
 |
|
  Z. Xie and G. M. Miller A Receptor Mechanism for Methamphetamine Action in Dopamine Transporter Regulation in Brain J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 316 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Troiano, R. de la Fuente-Fernandez, V. Sossi, M. Schulzer, E. Mak, T. J. Ruth, and A. J. Stoessl PET demonstrates reduced dopamine transporter expression in PD with dyskinesias Neurology, April 7, 2009; 72(14): 1211 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Santana, G. Mengod, and F. Artigas Quantitative Analysis of the Expression of Dopamine D1 and D2 Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex Cereb Cortex, April 1, 2009; 19(4): 849 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Furman, R. Chen, B. Guptaroy, M. Zhang, R. W. Holz, and M. Gnegy Dopamine and Amphetamine Rapidly Increase Dopamine Transporter Trafficking to the Surface: Live-Cell Imaging Using Total Internal Reflection Fluorescence Microscopy J. Neurosci., March 11, 2009; 29(10): 3328 - 3336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Chen, C. A. Furman, M. Zhang, M. N. Kim, R. W. Gereau IV, M. Leitges, and M. E. Gnegy Protein Kinase C{beta} Is a Critical Regulator of Dopamine Transporter Trafficking and Regulates the Behavioral Response to Amphetamine in Mice J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 912 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bertolino, L. Fazio, A. Di Giorgio, G. Blasi, R. Romano, P. Taurisano, G. Caforio, L. Sinibaldi, G. Ursini, T. Popolizio, et al. Genetically Determined Interaction between the Dopamine Transporter and the D2 Receptor on Prefronto-Striatal Activity and Volume in Humans J. Neurosci., January 28, 2009; 29(4): 1224 - 1234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. V. Mortensen, M. B. Larsen, B. M. Prasad, and S. G. Amara Genetic Complementation Screen Identifies a Mitogen-activated Protein Kinase Phosphatase, MKP3, as a Regulator of Dopamine Transporter Trafficking Mol. Biol. Cell, July 1, 2008; 19(7): 2818 - 2829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Xie and G. M. Miller {beta}-Phenylethylamine Alters Monoamine Transporter Function via Trace Amine-Associated Receptor 1: Implication for Modulatory Roles of Trace Amines in Brain J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 617 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Samuvel, L. D. Jayanthi, S. Manohar, K. Kaliyaperumal, R. E. See, and S. Ramamoorthy Dysregulation of Dopamine Transporter Trafficking and Function after Abstinence from Cocaine Self-Administration in Rats: Evidence for Differential Regulation in Caudate Putamen and Nucleus Accumbens J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 293 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zapata, B. Kivell, Y. Han, J. A. Javitch, E. A. Bolan, D. Kuraguntla, V. Jaligam, M. Oz, L. D. Jayanthi, D. J. Samuvel, et al. Regulation of Dopamine Transporter Function and Cell Surface Expression by D3 Dopamine Receptors J. Biol. Chem., December 7, 2007; 282(49): 35842 - 35854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Marazziti, S. Mandillo, C. Di Pietro, E. Golini, R. Matteoni, and G. P. Tocchini-Valentini GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs PNAS, June 5, 2007; 104(23): 9846 - 9851. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
